Regenome Spray
Advanced oily spray dressing for damaged skin free from antibiotics and cortisone.
Rigenoma® Spray with Ozoile® is a bioactive topical dressing in a propellant-free, oil-based formulation, developed for the management and protection of acute and chronic, infected and non-infected skin wounds, both in the cleansed and uncleansed phase. This innovative formulation has been designed to target the early and advanced stages of the wound, supporting the tissue repair process, preventing secondary infections, and helping to shorten healing times while simultaneously reducing symptoms such as itching, pain, and irritation, with a direct impact on patient comfort.
Rigenoma® Spray creates a protective lipid barrier with a film-forming effect that maintains the ideal moist environment for tissue repair, promoting re-epithelialization without interfering with skin physiology. Its effectiveness is particularly significant in the management of bedsores, vascular and metabolic ulcers, pressure sores, surgical or traumatic wounds, as well as inflammatory dermatological conditions such as dermatitis, eczema, redness, and abrasions, including the treatment of skin reactions from radiotherapy.
The gas-free spray application method allows for uniform, atraumatic, and hygienically safe application, making the product particularly suitable for both professional use in hospitals and outpatient clinics, as well as for home use by caregivers and family members. This feature, combined with its skin-friendly properties and absence of irritants, makes Rigenoma® Spray an effective and easy-to-use tool for the daily management of fragile skin, even in bedridden, elderly, or otherwise physically challenged individuals.
Validated by clinical evaluations
More than the drug, without the drug.
Mechanism of Action
The antimicrobial activity of Ozoile® creates a breathable lipid film with a barrier/protective effect and affects cellular redox balance, which in turn triggers antimicrobial, anti-inflammatory, antipruritic, and regenerative effects. This creates an environment favorable to skin repair and proper healing, protecting and respecting the skin. The antimicrobial effect, free of conventional antibiotics or antiseptics, acts selectively without altering the balance of the resident skin microbiota, while ensuring a high safety profile even with prolonged or repeated applications.
How to use
After cleansing the wound with Rigenoma® No-Rinse Cleanser, spray Rigenoma® Spray directly onto the affected area: one spray every 4 cm² approximately, from a distance of 5 cm. Protect the periwound skin for at least 1-2 cm with an even layer of Rigenoma® Cream. Renew the dressing two to three times a week depending on wound exudation. Cover with Rigenoma® Gauze in at least a double layer, folded or "tile-shaped", to create a semi-occlusion.
Mechanism of Action
The antimicrobial activity of Ozoile® creates a breathable lipid film with a barrier/protective effect and affects cellular redox balance, which in turn triggers antimicrobial, anti-inflammatory, antipruritic, and regenerative effects. This creates an environment favorable to skin repair and proper healing, protecting and respecting the skin. The antimicrobial effect, free of conventional antibiotics or antiseptics, acts selectively without altering the balance of the resident skin microbiota, while ensuring a high safety profile even with prolonged or repeated applications.
How to use
After cleansing the wound with Rigenoma® No-Rinse Cleanser, spray Rigenoma® Spray directly onto the affected area: one spray every 4 cm² approximately, from a distance of 5 cm. Protect the periwound skin for at least 1-2 cm with an even layer of Rigenoma® Cream. Renew the dressing two to three times a week depending on wound exudation. Cover with Rigenoma® Gauze in at least a double layer, folded or "tile-shaped", to create a semi-occlusion.
Ozoile® (Stable Ozonides with Vitamin E Acetate), Melaleuca Alternifolia Leaf Oil, Thioctic Acid
Ozoile® (Stable Ozonides with Vitamin E Acetate), Melaleuca Alternifolia Leaf Oil, Thioctic Acid
The purchase of our products is governed by clear and transparent terms, compliant with the Consumer Code and the GDPR. All prices include VAT, with fast shipping via GLS courier. Orders are accompanied by a guarantee of conformity and right of withdrawal within 14 days.
For more details on payments, deliveries and return policies, please see the dedicated section on our official website. We are always available for support and assistance at the contacts indicated.
The purchase of our products is governed by clear and transparent terms, compliant with the Consumer Code and the GDPR. All prices include VAT, with fast shipping via GLS courier. Orders are accompanied by a guarantee of conformity and right of withdrawal within 14 days.
For more details on payments, deliveries and return policies, please see the dedicated section on our official website. We are always available for support and assistance at the contacts indicated.
Regenome Spray
Advanced oily spray dressing for damaged skin free from antibiotics and cortisone.
Rigenoma® Spray with Ozoile® is a bioactive topical dressing in a propellant-free, oil-based formulation, developed for the management and protection of acute and chronic, infected and non-infected skin wounds, both in the cleansed and uncleansed phase. This innovative formulation has been designed to target the early and advanced stages of the wound, supporting the tissue repair process, preventing secondary infections, and helping to shorten healing times while simultaneously reducing symptoms such as itching, pain, and irritation, with a direct impact on patient comfort.
Rigenoma® Spray creates a protective lipid barrier with a film-forming effect that maintains the ideal moist environment for tissue repair, promoting re-epithelialization without interfering with skin physiology. Its effectiveness is particularly significant in the management of bedsores, vascular and metabolic ulcers, pressure sores, surgical or traumatic wounds, as well as inflammatory dermatological conditions such as dermatitis, eczema, redness, and abrasions, including the treatment of skin reactions from radiotherapy.
The gas-free spray application method allows for uniform, atraumatic, and hygienically safe application, making the product particularly suitable for both professional use in hospitals and outpatient clinics, as well as for home use by caregivers and family members. This feature, combined with its skin-friendly properties and absence of irritants, makes Rigenoma® Spray an effective and easy-to-use tool for the daily management of fragile skin, even in bedridden, elderly, or otherwise physically challenged individuals.
Validated by clinical evaluations
More than the drug, without the drug.
Mechanism of Action
The antimicrobial activity of Ozoile® creates a breathable lipid film with a barrier/protective effect and affects cellular redox balance, which in turn triggers antimicrobial, anti-inflammatory, antipruritic, and regenerative effects. This creates an environment favorable to skin repair and proper healing, protecting and respecting the skin. The antimicrobial effect, free of conventional antibiotics or antiseptics, acts selectively without altering the balance of the resident skin microbiota, while ensuring a high safety profile even with prolonged or repeated applications.
How to use
After cleansing the wound with Rigenoma® No-Rinse Cleanser, spray Rigenoma® Spray directly onto the affected area: one spray every 4 cm² approximately, from a distance of 5 cm. Protect the periwound skin for at least 1-2 cm with an even layer of Rigenoma® Cream. Renew the dressing two to three times a week depending on wound exudation. Cover with Rigenoma® Gauze in at least a double layer, folded or "tile-shaped", to create a semi-occlusion.
Mechanism of Action
The antimicrobial activity of Ozoile® creates a breathable lipid film with a barrier/protective effect and affects cellular redox balance, which in turn triggers antimicrobial, anti-inflammatory, antipruritic, and regenerative effects. This creates an environment favorable to skin repair and proper healing, protecting and respecting the skin. The antimicrobial effect, free of conventional antibiotics or antiseptics, acts selectively without altering the balance of the resident skin microbiota, while ensuring a high safety profile even with prolonged or repeated applications.
How to use
After cleansing the wound with Rigenoma® No-Rinse Cleanser, spray Rigenoma® Spray directly onto the affected area: one spray every 4 cm² approximately, from a distance of 5 cm. Protect the periwound skin for at least 1-2 cm with an even layer of Rigenoma® Cream. Renew the dressing two to three times a week depending on wound exudation. Cover with Rigenoma® Gauze in at least a double layer, folded or "tile-shaped", to create a semi-occlusion.
Ozoile® (Stable Ozonides with Vitamin E Acetate), Melaleuca Alternifolia Leaf Oil, Thioctic Acid
Ozoile® (Stable Ozonides with Vitamin E Acetate), Melaleuca Alternifolia Leaf Oil, Thioctic Acid
The purchase of our products is governed by clear and transparent terms, compliant with the Consumer Code and the GDPR. All prices include VAT, with fast shipping via GLS courier. Orders are accompanied by a guarantee of conformity and right of withdrawal within 14 days.
For more details on payments, deliveries and return policies, please see the dedicated section on our official website. We are always available for support and assistance at the contacts indicated.
The purchase of our products is governed by clear and transparent terms, compliant with the Consumer Code and the GDPR. All prices include VAT, with fast shipping via GLS courier. Orders are accompanied by a guarantee of conformity and right of withdrawal within 14 days.
For more details on payments, deliveries and return policies, please see the dedicated section on our official website. We are always available for support and assistance at the contacts indicated.
FAQ
It can be used every day to maintain bacterial flora balance.
It can be used every day to maintain bacterial flora balance.
